PATENT CLAIM ANALYSIS

Application Number: 15864665
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["514", "220000"]

Abstract:
Disclosed is a composition for the prevention or treatment of diabetic complications, containing a benzodiazepine-based compound, thereby effectively preventing or treating diseases resulting from hyperglycemia, which is the leading cause of diabetes, especially diseases caused by vascular leakage.

Claim (Index 3):
The method of  claim 1 , wherein the diabetic complications includes at least one selected from among diabetic retinopathy, diabetic stroke, diabetic cardiovascular disease, diabetic kidney disease, diabetic lung disease, diabetic peripheral neuropathy and diabetic cancer metastasis.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.26471
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15593767', '13987543', '15335271', '11136254', '11297808']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7604422401949725
- 35 USC 102 Novelty (BERT): 0.5260617558463636
- Combined Prediction Score: 0.7370041917601116
- Mean Citation Score: 214.27957200000003
- Max Citation Score: 316.6147
- Similarity Product: 199.9606791342736

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test